
AMN Healthcare is rated BUY, driven by robust nurse staffing demand and strong YTD share price performance (+110%). AMN trades at a compelling 5.2x forward EV/EBITDA, a 59% discount to the sector and 32% below its five-year average. Secular nurse shortages, AI-driven operational efficiencies, and improving margins underpin AMN's positive outlook and earnings momentum.










